1. Rule 1: If a molecule contains a functional group such as an alcohol, aldehyde, or ketone, it is more likely to cause adverse effects.
2. Rule 2: If a molecule contains a halogen atom such as fluorine, chlorine, or bromine, it is more likely to cause adverse effects.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is more likely to cause adverse effects.
These rules are based on the observation that molecules with these functional groups or structures are more likely to interact with biological systems and cause adverse effects. However, it is important to note that these rules are not always accurate and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a sulfonamide group (-SO2NH2), it is more likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a carboxylic acid group (-COOH), it is more likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to respiratory disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to neurological disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to dermatological disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, C(CC(=O)O)[C@@H](C(=O)O)NC(=O)N, contains a carbonyl group (C=O) and is labeled as 0, which means it is not related to adverse effects related to hepatobiliary disorders. This suggests that the presence of a carbonyl group alone is not sufficient to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: The second molecule, CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC, contains a nitro group (-NO2) and is labeled as 0, which means it is not related to adverse effects related to neurological disorders. This suggests that the presence of a nitro group alone is not sufficient to cause adverse effects related to neurological disorders.
3. Rule 3: The third molecule, CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C, contains a chlorine atom and is labeled as 1, which means it is related to adverse effects related to dermatological disorders. This suggests that the presence of a chlorine atom alone is not sufficient to cause adverse effects related to dermatological disorders.
However, it is important to note that these rules are based on the given data and may not be applicable to all cases. It is always recommended to consult with a qualified chemist before making any conclusions about the potential adverse effects of a molecule.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a sulfonamide group (-SO2NH2), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to gastrointestinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with the smiles string "CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O" contains a nitro group (-NO2). Therefore, it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: The molecule with the smiles string "CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O" contains a sulfonamide group (-SO2NH2). Therefore, it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: The molecule with the smiles string "CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O" contains a carboxylic acid group (-COOH). Therefore, it is likely to cause adverse effects related to gastrointestinal disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can interact with

================================

1. Rule 1: If a molecule contains a functional group such as an amide, imide, or urea group, it is more likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is more likely to cause adverse effects related to respiratory disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a benzene ring, it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a significant indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also a significant indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom (such as fluorine, chlorine, or bromine) in a molecule is also a significant indicator of its potential to cause adverse effects.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups are more likely to cause adverse effects than molecules without them. However, it is important to note that these rules are not absolute and there may be exceptions to them. Therefore, it is important to use these rules as a starting point and to conduct further research to confirm their accuracy.

================================

1. Rule 1: If the molecule contains a calcium ion, it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a nitrogen atom, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains both a calcium ion and a nitrogen atom, it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If a molecule contains a functional group such as an amidine group (-C(=NH)-NH-) or a guanidine group (-C(=NH)-NH-), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2) or a cyano group (-CN), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a functional group such as a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to neurological disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with the smiles string "C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F" contains a nitro group (-NO2). This suggests that the molecule may have adverse effects related to hepatobiliary disorders.
2. Rule 2: The molecule with the smiles string "CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2" contains a chlorine atom (-Cl). This suggests that the molecule may have adverse effects related to dermatological disorders.
3. Rule 3: The molecule with the smiles string "C1N2CN3CN1CN(C2)C3" contains a benzene ring (C6H5). This suggests that the molecule may have adverse effects related to neurological disorders.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects.
These rules are based on the data provided and can be used to predict whether a new molecule is likely to cause adverse effects based on its structure.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a sulfonyl group (-SO2-), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to neurological disorders.
These rules are based on the observation that the molecules with these functional groups are more likely to cause adverse effects than those without them. However, it is important to note that these rules are not foolproof and there may be other factors that contribute to the adverse effects of a molecule.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects related to skin and eye irritation.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to respiratory disorders.
These rules can be inferred by analyzing the labels and structures of the molecules in the data. For example, the molecule with the smiles string "CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F 1" contains a nitro group and is labeled as causing adverse effects related to hepatobiliary disorders. Similarly, the molecule with the smiles string "C[C@@H](C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(=O)O)N[C@@H](CCC3=CC=CC=C3)C(=O)O 1" contains a halogen atom and is labeled as causing adverse effects related to skin and eye irritation. Finally, the molecule with the smiles string "C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F 1" contains a carbonyl group and is labeled as causing adverse effects related to respiratory disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains both a nitro group and a carboxylic acid group, it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.
Explanation:
1. The first rule is based on the fact that nitro groups are commonly found in drugs that are associated with adverse effects related to hepatobiliary disorders. Nitro groups can interact with the liver and bile ducts, leading to liver damage and cholestasis.
2. The second rule is based on the fact that chlorine atoms are commonly found in drugs that are associated with adverse effects related to hepatobiliary disorders. Chlorine atoms can interact with the liver and bile ducts, leading to liver damage and cholestasis.
3. The third rule is based on the fact that carbonyl groups are commonly found in drugs that are associated with adverse effects related to hepatobiliary disorders. Carbonyl groups can interact with the liver and bile ducts, leading to liver damage and cholestasis.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to gastrointestinal disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with label 1, C(=O)(N)NO, contains a nitro group (-NO2). This suggests that the molecule is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: The molecule with label 0, CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C, contains a chlorine atom (-Cl). This suggests that the molecule is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: The molecule with label 0, CC1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N, contains a carboxylic acid group (-COOH). This suggests that the molecule is likely to cause adverse effects related to gastrointestinal disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a hydroxyl group (-OH), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
Explanation:
1. Rule 1 is based on the observation that many molecules that cause adverse effects related to hepatobiliary disorders contain functional groups such as carbonyl groups (C=O) or hydroxyl groups (-OH). These functional groups can interact with the liver and other organs, leading to toxicity.
2. Rule 2 is based on the observation that many molecules that cause adverse effects related to hepatobiliary disorders contain polycyclic aromatic hydrocarbon (PAH) structures. PAHs can interact with the liver and other organs, leading to toxicity.
3. Rule 3 is based on the observation that many molecules that cause adverse effects related to hepatobiliary disorders contain nitro groups (-NO2). Nitro groups can interact with the liver and other organs, leading to toxicity.
These rules can be used to predict whether a new molecule is likely to cause adverse effects related to hepatobiliary disorders based on its chemical structure.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom (Cl), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to respiratory disorders.
These rules can be inferred by analyzing the labels associated with the smiles strings in the data. For example, the first rule can be inferred by analyzing the label associated with the smiles string "N(=O)[O-]", which is 0. This indicates that the molecule is not related to hepatobiliary disorders. However, the presence of a nitro group (-NO2) in the molecule suggests that it may have adverse effects related to hepatobiliary disorders. Similarly, the second and third rules can be inferred by analyzing the labels associated with the smiles strings "CC(C)NCC(C1=CC(=C(C=C1)O)O)O" and "CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F", respectively.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to neurological disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with the smiles string [O-2].[O-2].[O-2].[As+3].[As+3] 1 contains a nitro group (-NO2), which is known to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: The molecule with the smiles string C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C.C(=O)(C(F)(F)F)O 0 contains a chlorine atom (-Cl), which is known to cause adverse effects related to dermatological disorders.
3. Rule 3: The molecule with the smiles string CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-] 1 contains a benzene ring (

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to hepatobiliary disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with the smiles string "CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8" contains a nitro group (-NO2) and a carbonyl group (-C=O). It is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: The molecule with the smiles string "CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to respiratory disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with label 1, C[C@H]1C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(=O)N[C@@H](CC4=CC=C(C=C4)O)C(=O)O)C(=O)N[C@@H](CSSC[C@@H](C(=O)N3)N)C(=O)N[C@H](C(=O)N5CCC[C@H]5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O.CC(=O)O 0, contains a nitro group (-NO2).
2. Rule 2: The molecule with label 0, CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N 1, contains a halogen atom (fluorine).
3. Rule 3: The molecule with label 0, CCCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC.Cl 0, contains

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If a molecule contains a bromine atom (-Br), it is likely to cause adverse effects related to respiratory disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O), it is more likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is more likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a functional group such as a sulfonamide group (-SO2NH2), it is more likely to cause adverse effects related to hepatobiliary disorders.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups are more likely to cause adverse effects related to hepatobiliary disorders. However, it is important to note that these rules are not always accurate and should be used as a starting point for further analysis and experimentation.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a fluorine atom (-F) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a fluorine atom (-F) in a molecule increases the likelihood of causing adverse effects. This is because fluorine atoms have a high electronegativity and can interact with biological molecules, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects. This is because chlorine atoms have a high electronegativity and can interact with biological molecules, which can lead to toxicity and adverse effects.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If the molecule contains a nitro group, it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a benzene ring, it is likely to cause adverse effects related to hepatobiliary disorders.
Explanation:
1. The first rule is based on the observation that nitro groups are commonly found in drugs that are associated with adverse effects related to hepatobiliary disorders. Nitro groups can interact with the liver and cause damage to the liver cells. Therefore, if a molecule contains a nitro group, it is likely to cause adverse effects related to hepatobiliary disorders.
2. The second rule is based on the observation that carboxylic acid groups are commonly found in drugs that are associated with adverse effects related to hepatobiliary disorders. Carboxylic acid groups can interact with the liver and cause damage to the liver cells. Therefore, if a molecule contains a carboxylic acid group, it is likely to cause adverse effects related to hepatobiliary disorders.
3. The third rule is based on the observation that benzene rings are commonly found in drugs that are associated with adverse effects related to hepatobiliary disorders. Benzene rings can interact with the liver and cause damage to the liver cells. Therefore, if a molecule contains a benzene ring, it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.
These rules can be inferred from the given data as follows:
1. The first molecule (CC1=C(C(C(=C(N1)C)C(=O)OCC[NH+](C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC 0) contains a nitro group (-NO2), which suggests that it may have adverse effects related to hepatobiliary disorders.
2. The second molecule (C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O 0) contains a halogen atom (fluorine), which suggests that it may have adverse effects related to hepatobiliary disorders.
3. The third molecule (C1=CC(=CC=C1CN)S(=O)(=O)N 0) contains a carbonyl group (-C=O), which suggests that it may have adverse effects related to hepatobiliary disorders.
4. The fourth molecule (CC(=O)[O-].CC(=O)[O-].[Ca+2] 0) contains a halogen atom (calcium), which suggests that it may have adverse effects related to hepatobiliary disorders.
5. The fifth molecule (CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F 1) contains a carbonyl group (-C

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to gastrointestinal disorders.
These rules can be inferred by analyzing the labels and structures of the molecules in the data. For example, the first molecule, C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O 1, has a nitro group (-NO2) and is labeled as causing adverse effects related to hepatobiliary disorders. Similarly, the second molecule, C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)N=C(N=C2N)Cl 1, has a chlorine atom (-Cl) and is labeled as causing adverse effects related to dermatological disorders. Finally, the third molecule, CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C(=O)[O-], has a carboxylic acid group (-COOH) and is labeled as causing adverse effects related to gastrointestinal disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.
Explanation:
- Rule 1: The molecule contains a nitro group (-NO2), which is known to cause adverse effects related to hepatobiliary disorders.
- Rule 2: The molecule contains a chlorine atom (-Cl), which is known to cause adverse effects related to hepatobiliary disorders.
- Rule 3: The molecule contains a carbonyl group (-C=O), which is known to cause adverse effects related to hepatobiliary disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains the substructure "C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl", it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains the substructure "C1=CC(=C(C=C1CCN)O)O", it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains the substructure "C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)C)C)O)O)/C", it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
4. Rule 4: The presence of a double bond between carbon atoms (-C=C-) in a molecule increases the likelihood of causing adverse effects.
5. Rule 5: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects.
6. Rule 6: The presence of a double bond between nitrogen atoms (-N=N-) in a molecule increases the likelihood of causing adverse effects.
7. Rule 7: The presence of a double bond between oxygen atoms (-O=O-) in a molecule increases the likelihood of causing adverse effects.
8. Rule 8: The presence of a double bond between sulfur atoms (-S=S-) in a molecule increases the likelihood of causing adverse effects.
9. Rule 9: The presence of a double bond between carbon and nitrogen atoms (-C=N-) in a molecule increases the likelihood of causing adverse effects.
10. Rule 10: The presence of a double bond between carbon and oxygen atoms (-C=O-) in a molecule increases the likelihood of causing adverse effects.
11. Rule 11: The presence of a double bond between carbon and sulfur atoms (-C=S-) in a molecule increases the likelihood of causing adverse effects.
12. Rule 12: The presence of a double bond between nitrogen and oxygen atoms (-N=O-) in a molecule increases the likelihood of causing adverse effects.
13. Rule 13: The presence of a double bond between nitrogen and sulfur atoms (-N=S-) in a molecule increases the likelihood of causing adverse effects.
14. Rule 14: The presence of a double bond between oxygen and sulfur atoms (-O=S-) in a molecule increases the likelihood of causing adverse effects.
15. Rule 15: The presence of a

================================

1. Rule 1: If the molecule contains a nitro group, it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to hepatobiliary disorders.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to hepatobiliary disorders.
These rules are based on the data provided and can be used to predict whether a new molecule is likely to cause adverse effects related to hepatobiliary disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a chlorine atom, it is more likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a carbonyl group, it is more likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a benzene ring, it is more likely to cause adverse effects related to hepatobiliary disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The first molecule, C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl, contains a chlorine atom and is related to the side-effect activity of a molecule related to hepatobiliary disorders.
2. Rule 2: The second molecule, CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O, contains a carbonyl group and is related to the side-effect activity of a molecule related to hepatobiliary disorders.
3. Rule 3: The third molecule, CC1(O[C@@H]2C[C@H]3C4CCC5=CC(=O)C=CC5([C@H]4C(CC3([C@@]2(O1)C(=O)CO)C)O)C)C, contains a benzene ring and is related to the side-effect activity of a molecule related to hepatobiliary disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to hepatobiliary disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with label 1, C1=C(C=C(C(=C1NC(=O)C(=O)O)Cl)NC(=O)C(=O)O)C#N, contains a nitro group (-NO2). Therefore, it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: The molecule with label 1, C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O, contains a carboxylic acid group (-COOH). Therefore, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: The molecule with label 1, C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl 1, contains a chlorine atom (-Cl). Therefore, it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If a molecule contains a functional group such as an amidine or guanidine group, it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a nitro group, it is likely to cause adverse effects related to hepatobiliary disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a sulfonamide group (-SO2NH2), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to hepatobiliary disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule with label 1, CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=CCS3)C(=O)O, contains a nitro group (-NO2). The molecule with label 0, CCC1CCC[C@@H](C(C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C=C[C@H]3[C@@H]2CC(=O)O1)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CCC([C@H](O6)C)N(C)C, does not contain a nitro group. Therefore, the presence of a nitro group in a molecule is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: The molecule with label 1, C[N+](C)(C)CC(CC(=O)O)O, contains a sulfonamide group (-SO2NH2). The molecule with label 0, C(C(C(C(C(CO)O)O)O)O)O, does not contain a sulfonamide group. Therefore, the presence of a sulfonamide group in a molecule is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: The molecule with label 1, C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N, contains a carboxylic acid group (-COOH). The molecule with label 0, CCC1CCC[C@@H](C(C(=O)C2=C[C@H]3[C@@H]4C[C@@H](C[C@H]4C(=C[C@H]3[C@@H]2CC(=O)O1)C)O[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)C)OC)OC)OC)C)O[C@H]6CCC([C@H](O6)C)N(C)C, does not contain a carboxylic acid group. Therefore, the presence of a carboxylic acid group in a molecule is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.

================================

